Efficacy on prophylactic topical steroid for rash in patients treated eith Erlotinib - Efficacy on prophylactic topical steroid for rash in patients treated eith Erlotinib

Showa University Northern Yokohama Hospital0 个研究点目标入组 14 人开始时间: 2018年4月10日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Patients with superior vena caval syndrome 2)Patients with compressive spinal cord lesion 3)History of hypersensitivity for drugs 4)Patients with brain metastasis or anticonvulsant medication 5)Patients with severe skin disease or treated by steroid 6)Patients with idiopathic pulomary fibrosis,pneumoconiosis,other interstitial pneumonia,idiopathic pulmonary,drug induced pulmonary damage or lungs inflammation 7)Interval from precious treatment,of following,at enrollment a)Equal or more than 4 weeks after b)Equal or more than 2 weeks after 8)active fluid in the abdomen or pleural effusion 9)Other clinically significant complications 10)Clinically significant eye diseases 11)Patients with diverticulitis 12)History of perforation of the digestive tract within one years 13)Other clinically significant cardiac disease 14)Other clinically significant psychiatric disease 15)Pregnancy,breast feeding and suspecterd pregnancy

发起方

Showa University Northern Yokohama Hospital